PyInvesting

Market research

RKDA Arcadia Biosciences Inc

NASDAQ USD Consumer Defensive

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
1M
P/E ratio
Not available
Analyst target
12
Dividend yield
Not available
Beta
0.55

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Arcadia Biosciences, Inc is currently in a long term downtrend where the price is trading 8.0% below its 200 day moving average.

From a valuation standpoint, the stock is 65.4% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 3.4.

Arcadia Biosciences, Inc's total revenue rose by 1613.9% to $7M since the same quarter in the previous year.

Its net income has increased by 242.5% to $9M since the same quarter in the previous year.

Finally, its free cash flow fell by 25.6% to $-7M since the same quarter in the previous year.

Based on the above factors, Arcadia Biosciences, Inc gets an overall score of 3/5.